San Jose, CA, October 20, 2021: Natera, the leading clinical genetics company licenses OptraHEALTH's, patented conversational AI technology for their initiatives related to patients and physician communications. OptraHEALTH’s flagship product HealthFAX™.AI is empowered by this patented technology to enhance patient education, experience and ultimately care for patients.
“Our advanced and patented AI technology coupled with Natera’s world-class clinical genetics testing solutions will empower Natera for their patient engagement related initiatives This endorses the power of our IP in the Healthcare segment”, said Dr. Gauri Naik, Co-Founder & CEO, OptraHEALTH, Inc.
OptraHEALTH® is focused on improving outcomes for consumers and leading Life Sciences and Healthcare organizations by utilizing our next-generation Artificial Intelligence Platform. OptraHEALTH’s flagship product GeneFAX™ is an AI-powered Knowledge Platform for Genetic Health and is available as a Web Plugin or Mobile application.
Media Inquiries Contact: